Luijendijk Mirjam W J, Van Wijk Erwin, Bischoff Anne M L C, Krieger Elmar, Huygen Patrick L M, Pennings Ronald J E, Brunner Han G, Cremers Cor W R J, Cremers Frans P M, Kremer Hannie
Department of Human Genetics, University Medical Center Nijmegen, Nijmegen, The Netherlands.
Hum Genet. 2004 Jul;115(2):149-56. doi: 10.1007/s00439-004-1137-3. Epub 2004 Jun 2.
Myosin VIIA is an unconventional myosin that has been implicated in Usher syndrome type 1B, atypical Usher syndrome, non-syndromic autosomal recessive hearing impairment (DFNB2) and autosomal dominant hearing impairment (DFNA11). Here, we present a family with non-syndromic autosomal dominant hearing impairment that clinically resembles the previously published DFNA11 family. The affected family members show a flat audiogram at young ages and only modest progression, most clearly at the high frequencies. In addition, they suffer from minor vestibular symptoms. Linkage analysis yielded a maximum two-point lodscore of 3.43 for marker D11S937 located within 1 cM of the myosin VIIA gene. The myosin VIIA gene was sequenced and 11 nucleotide variations were found. Ten nucleotide changes represent benign intronic variants, silent exon mutations or non-pathologic amino acid substitutions. One variant, a c.1373A-->T transversion that is heterozygously present in all affected family members and absent in 300 healthy individuals, is predicted to result in an Asn458Ile amino acid substitution. Asn458 is located in a region of the myosin VIIA motor domain that is highly conserved in different classes of myosins and in myosins of different species. To evaluate whether the Asn458Ile mutation was indeed responsible for the hearing impairment, a molecular model of myosin VIIA was built based on the known structure of the myosin II heavy chain from Dictyostelium discoideum. In this model, conformational changes in the protein caused by the amino acid substitution Asn458Ile are predicted to disrupt ATP/ADP binding and impair the myosin power-stroke, which would have a severe effect on the function of the myosin VIIA protein.
肌球蛋白VIIA是一种非常规肌球蛋白,与1B型Usher综合征、非典型Usher综合征、非综合征性常染色体隐性听力障碍(DFNB2)以及常染色体显性听力障碍(DFNA11)有关。在此,我们报道一个非综合征性常染色体显性听力障碍家系,其临床表现与先前报道的DFNA11家系相似。受影响的家庭成员在年轻时听力图呈平坦型,进展缓慢,最明显的是在高频区。此外,他们还伴有轻微的前庭症状。连锁分析显示,位于肌球蛋白VIIA基因1厘摩范围内的标记D11S937的最大两点连锁值为3.43。对肌球蛋白VIIA基因进行测序,发现了11个核苷酸变异。其中10个核苷酸变化代表良性内含子变异、沉默外显子突变或非病理性氨基酸替代。一个变异,即c.1373A→T颠换,在所有受影响的家庭成员中呈杂合状态,而在300名健康个体中未出现,预计会导致Asn458Ile氨基酸替代。Asn458位于肌球蛋白VIIA运动结构域的一个区域,该区域在不同类别的肌球蛋白以及不同物种中的肌球蛋白中高度保守。为了评估Asn458Ile突变是否确实是导致听力障碍的原因,基于盘基网柄菌肌球蛋白II重链的已知结构构建了肌球蛋白VIIA的分子模型。在这个模型中,预测由Asn458Ile氨基酸替代引起的蛋白质构象变化会破坏ATP/ADP结合并损害肌球蛋白的动力冲程,这将对肌球蛋白VIIA蛋白的功能产生严重影响。